advertisement
Eye 18
Showing records 1 to 18 | Display all abstracts in Eye5930 The genetics of open-angle glaucoma: the story of GLC1A and myocilin
Alward WLM
Eye 2000; 14: 429-436
5945 Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells
Polansky JR; Fauss DJ; Zimmerman CC
Eye 2000; 14: 503-514
5946 Molecular genetics of primary congenital glaucoma
Sarfarazi M; Stoilov I
Eye 2000; 14: 422-428
5961 Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage
Morgan JE
Eye 2000; 14: 437-444
5967 Anterior optic nerve microvascular changes in human glaucomatous optic neuropathy
Zhao DY; Cioffi GA
Eye 2000; 14: 445-449
5971 The rate of blindness and of partial sight registration in glaucoma patients
King AJ; Reddy A; Thompson JR; Rosenthal AR
Eye 2000; 14: 613-619
5999 Use of the GDx to detect differences in retinal nerve fibre layer thickness between normal, ocular hypertensive and early glaucomatous eyes
Kamal DS; Bunce C; Hitchings RA
Eye 2000; 14: 367-370
6004 Nerve fibre layer measurement of the Hong Kong Chinese population by scanning laser polarimetry
Lee VW; Mok KH
Eye 2000; 14: 371-374
6118 Acute angle closure glaucoma presenting in a young patient after administration of paroxytone
Browning AC; Reck AC; Chisholm IH; Nischal KK
Eye 2000; 14: 406-408
6130 Pigment dispersion syndrome and butterfly-shaped pattern dystrophy of the retinal pigment epithelium
Kadayifcilar S; Tatlipinar S; Eldem B; Irkec M
Eye 2000; 14: 663-665
6155 Anterior ischaemic optic neuropathy associated with central retinal vein occlusion
Ab El-Asrar AM; Al Rashaed SA; Abdel Gader AGM
Eye 2000; 14: 560-562
6159 Glaucoma mimicked by carotid-ophthalmic artery aneurysm: a rare insidious cause of progressive visual loss
Kulkarni AA; Hope-Rose M; Beale DJ; Byrne JV
Eye 2000; 14: 405-406
6161 Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy
Salomon O; Huna-Baron R; Steinberg DM; Kurtz S; Seligsohn U
Eye 1999; 13: 357-359
6164 Glaucoma medical treatment: Philosophy, principles and practice
Migdal C
Eye 2000; 14: 515-518
6206 In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
Haefliger IO; Fleischhauer JC; Flammer J
Eye 2000; 14: 464-472
6209 5-hydroxytryptamine(1A) agonists: potential use in glaucoma. Evidence from animal studies
Osborne NN; Wood JPM; Melena J; Chao HM; Nash MS; Bron AJ; Chidlow G
Eye 2000; 14: 454-463
6245 Sinusotomy and deep sclerectomy
Mermoud A
Eye 2000; 14: 531-535
6291 Chronic glaucoma: definition of the phenotype
Hitchings RA
Eye 2000; 14: 419-421
